Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Lacidipine

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 6,777Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/09/2024 LEBSA
    Spain
    		 Jimax Pharmachem Co., Ltd. 20220216-209-J-1188 Lacidipine 2022-02-16 LABORATORIOS ESPINOS Y BOFILL SA (LEBSA) Spain Ctra. De L'Hospitalet, 34 08940 Cornellà De Llobregat, Barcelona, ​​Spain
    28/09/2024 GSK
    United Kingdom
    		 GlaxoSmithKline Inc. 20210513-209-J-988 Lacidipine 2021-05-13 Glaxo Operations UK Ltd (Trading as Glaxo Wellcome Operations) United Kingdom Cobden Street, Montrose, Angus, DD10 8EA, United Kingdom